OFF-LABEL USES OF APPROVED DRUGS A New Compromise is Needed

DSpace/Manakin Repository

OFF-LABEL USES OF APPROVED DRUGS A New Compromise is Needed

Citable link to this page

. . . . . .

Title: OFF-LABEL USES OF APPROVED DRUGS A New Compromise is Needed
Author: Pritchard, Robert H.
Citation: OFF-LABEL USES OF APPROVED DRUGS A New Compromise is Needed (1995 Third Year Paper)
Full Text & Related Files:
Abstract: Washington, D.C. is teeming with speculation regarding the likely effects of a new political scenery and the Republican Contract With America. As the new Congress is taking form and adjusting to a new reality, one voice stands out amid the uproar... House Speaker Newt Gingrich has an agenda, and his intentions, though not clearly spelled out, have certainly not been withheld from public discourse. One of Mr. Gingrich's strongly voiced concerns centers on structure of the FDA as it currently exists, and the effect that the entrenchment of bureaucracy has on the functioning of this agency. Mr. Gingrich frequently cites an example of a plunger-like cardiopulmonary resuscitation aid which, though invented in the United States and proven tremendously effective in Europe, is illegal and unavailable for use in this country.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965544

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters